Drug Trial Radar · NCT07447076
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
29
Planned (sponsor's estimate)
Start
Jun 17, 2026
Primary completion
Dec 31, 2035
Study completion Dec 31, 2036
Sponsor
- Lead sponsor
- Sabine Mueller, MD, PhDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Pacific Pediatric Neuro-Oncology Consortium; Rally Foundation
- First posted
- Mar 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 39 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-treatment arm study that will be conducted through the Pacific Pediatric Neuro-oncology Consortium (PNOC).The study will assess the safety and efficacy of novel therapies and combinatorial strategies for participants with recurrent or progressive ATRT.
Conditions
- Recurrent Atypical Teratoid/Rhabdoid Tumor
- Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS
Interventions
Lumber PunctureProcedure
Cerebral Spinal Fluid (CSF) will be collected for research
Blood Specimen CollectionProcedure
Perform blood draw
Magnetic resonance imaging (MRI)Procedure
Undergo imaging procedure
GemcitabineDrug
Given IV
PaxalisibDrug
Given orally (PO)
Tumor BiopsyProcedure
Undergo biopsy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Arm A (Phase I): Proportion of participants who experience dose-limiting toxicity (DLT)Time frame: up to 28 days
- Arm A (Phase I): Recommended Phase 2 Dose (RP2D) (Phase I)Time frame: up to 28 days
- Arm A (Phase II): Rate of Clinical BenefitTime frame: up to 2 years (24 cycles)
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Francisco
San Francisco, California · Not yet recruiting
University of California, San Francisco
San Francisco, California · Recruiting
John Hopkins Hospital
Baltimore, Maryland · Recruiting
Seattle Children's Hospital University of Washington, Seattle
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.